Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Mesothelioma × Observation × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 3 Prostatic Neoplasms 2 Mouth Neoplasms 2 Leukemia, Myelomonocytic, Acute 2 Leukemia, Monocytic, Acute 2 Leukemia, Megakaryoblastic, Acute 2 Leukemia, Erythroblastic, Acute 2 Carcinoma, Non-Small-Cell Lung 2 Squamous Intraepithelial Lesions 1 Smoldering Multiple Myeloma 1 Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Osteoporosis 1 Oropharyngeal Neoplasms 1 Obesity 1 Neurofibrosarcoma 1 Neuroblastoma 1 Neoplasms, Plasma Cell 1 Multiple Myeloma 1 Melanoma 1 Malignant mesenchymal tumor 1 Lymphoma, Mantle-Cell 1 Lymphoma 1 Lung Neoplasms 1 Liposarcoma 1 Leukemia, B-Cell 1 Leiomyosarcoma 1

Interventions

Pemetrexed 11 Cisplatin 10 pembrolizumab 7 Carboplatin 6 Ipilimumab 5 Nivolumab 4 durvalumab 3 LMB-100 3 Gemcitabine 3 tremelimumab 2 tazemetostat 2 anetumab ravtansine 2 Vinorelbine 2 Plicamycin 2 Dexamethasone 2 Cyclophosphamide 2 Bevacizumab 2 vandetanib 1 tocilizumab 1 ribociclib 1 rebastinib 1 pevonedistat 1 olaparib 1 niraparib 1 nintedanib 1 fludarabine phosphate 1 fludarabine 1 epacadostat 1 enzalutamide 1 defactinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡